Zobrazeno 1 - 10
of 479
pro vyhledávání: '"ZHENGGANG ZHU"'
Autor:
Ruixin Yang, Yao Qi, Wingyan Kwan, Yutong Du, Ranlin Yan, Lu Zang, Xuexin Yao, Chen Li, Zhenggang Zhu, Xiaoyan Zhang, Hengjun Gao, Io Hong Cheong, Zisis Kozlakidis, Yingyan Yu
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background Organoids are approved by the US FDA as an alternative to animal experiments to guide drug development and for sensitivity screening. Stable organoids models of gastric cancer are desirable for personalized medicine and drug scree
Externí odkaz:
https://doaj.org/article/8c999b9fe6e2499cb92af54f0aebb8a4
Autor:
Li Li, Jingyi Xu, Jiao Zhang, Fang Wang, Jianlin Cai, Liqing Yang, Zhenggang Zhu, Yunhua Bai, Bin Jia, Jianxin Ma, Nianmin Shi, Shuping Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
This study was a randomized, parallel-controlled of homologous vaccines with different immune procedure research to evaluate the immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals. 240 subje
Externí odkaz:
https://doaj.org/article/c1c0f20360de43e8a8f5e54529d5de1b
Autor:
Zhiyuan Fan, Fangyuan Li, Xiao Jiang, Tao Pan, Mingde Zang, Jianfang Li, Beiqin Yu, Qingqing Sang, Wentao Liu, Liping Su, Chen Li, Zhenggang Zhu, Min Yan, Chao Yan, Fei Yuan, Bingya Liu
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 11, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/d2b51eceaf024382a060fae18b641211
Autor:
Haoran Feng, Junxian Yu, Zhuoqing Xu, Qingqing Sang, Fangyuan Li, Mengdi Chen, Yunqin Chen, Beiqin Yu, Nan Zhu, Jiazeng Xia, Changyu He, Junyi Hou, Xiongyan Wu, Chao Yan, Zhenggang Zhu, Liping Su, Jianfang Li, Wentao Dai, Yuan-Yuan Li, Bingya Liu
Publikováno v:
EBioMedicine, Vol 109, Iss , Pp 105375- (2024)
Summary: Background: SLC7A9 is responsible for the exchange of dibasic amino acids and cystine (influx) for neutral amino acids (efflux). Cystine/cysteine transport is related to ferroptosis. Methods: Sanger sequencing detected TP53 status of cancer
Externí odkaz:
https://doaj.org/article/f7856e5a3f9f4553a49cef9061909ac9
Autor:
Qisheng Hou, Si Liu, Cheng Liu, Xu Wang, Jirong Shi, Qingjun Chen, Xinjun Lv, Zhenggang Zhu, Chuanlin Wang, Wenwu Yin
Publikováno v:
Travel Medicine and Infectious Disease, Vol 60, Iss , Pp 102735- (2024)
Background: The 4-dose Essen intramuscular (IM) regimen for rabies post-exposure prophylaxis (PEP) has been recommended by Advisory Committee on Immunization Practices (ACIP) and World Health Organization (WHO), but the large-sample clinical evidence
Externí odkaz:
https://doaj.org/article/8434bdfc2de345a28a6c3baf3ad9d215
Autor:
Ruixin Yang, Yutong Du, Wingyan Kwan, Ranlin Yan, Qimeng Shi, Lu Zang, Zhenggang Zhu, Jianming Zhang, Chen Li, Yingyan Yu
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 7, Pp 519-536 (2023)
Objective: Organoids are a powerful tool with broad application prospects in biomedicine. Notably, they provide alternatives to animal models for testing potential drugs before clinical trials. However, the number of passages for which organoids main
Externí odkaz:
https://doaj.org/article/427d4afa684847aca064953fa1000aaa
Autor:
Hong Yuan, Fei Xu, Shengzhou Wang, Di Liu, Huan Zhang, Jun Zhang, Min Shi, Chao Yan, Zhenggang Zhu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Circulating tumor DNA (ctDNA) is a promising technique for predicting curative effects and monitoring tumor recurrence. The utility of ctDNA for gastric cancer with peritoneal dissemination remains elusive. Objectives: To assess the feasi
Externí odkaz:
https://doaj.org/article/89de893030cb464c8556a13053385602
Publikováno v:
Nursing Open, Vol 10, Iss 5, Pp 2819-2830 (2023)
Abstract Aim To understand Baduanjin rehabilitation therapy in mild COVID‐19 patients. Design A narrative review. Methods A literature search for COVID‐19 and Baduanjin treatments was conducted on Chinese and English electronic databases: China N
Externí odkaz:
https://doaj.org/article/18d0b8d886604e7eaae2e0f246eb129f
Autor:
Fangyuan Li, Junxian Yu, Tao Pan, Haoran Feng, Jianfang Li, Beiqin Yu, Zhiyuan Fan, Qingqing Sang, Mengdi Chen, Mingde Zang, Junyi Hou, Xiongyan Wu, Yingyan Yu, Yuan‐Yuan Li, Chao Yan, Zhenggang Zhu, Liping Su, Bingya Liu
Publikováno v:
Advanced Science, Vol 10, Iss 34, Pp n/a-n/a (2023)
Abstract Erlotinib, an EGFR tyrosine kinase inhibitor, is used for treating patients with cancer exhibiting EGFR overexpression or mutation. However, the response rate of erlotinib is low among patients with gastric cancer (GC). The findings of this
Externí odkaz:
https://doaj.org/article/a52d13ec381e41e3b9daef4653ccf9a8
Autor:
Lizhong Yao, Junyi Hou, Xiongyan Wu, Yifan Lu, Zhijian Jin, Zhenjia Yu, Beiqin Yu, Jianfang Li, Zhongyin Yang, Chen Li, Min Yan, Zhenggang Zhu, Bingya Liu, Chao Yan, Liping Su
Publikováno v:
Redox Biology, Vol 67, Iss , Pp 102923- (2023)
As the predominant immunosuppressive component within the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) inhibit Natural Killer cell (NK cell) activity to promote tumor progression and immune escape; however, the mechanisms of cro
Externí odkaz:
https://doaj.org/article/1a8ad35e533843c1aa456774f9853db2